Salem Investment Counselors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $285K | Hold |
2,255
| – | – | 0.01% | 330 |
|
|
2025
Q1 | $288K | Hold |
2,255
| – | – | 0.01% | 318 |
|
|
2024
Q4 | $298K | Hold |
2,255
| – | – | 0.01% | 316 |
|
|
2024
Q3 | $328K | Hold |
2,255
| – | – | 0.01% | 311 |
|
|
2024
Q2 | $310K | Hold |
2,255
| – | – | 0.01% | 309 |
|
|
2024
Q1 | $309K | Buy |
2,255
+55
| +3% | +$7.55K | 0.01% | 311 |
|
|
2023
Q4 | $299K | Hold |
2,200
| – | – | 0.01% | 305 |
|
|
2023
Q3 | $269K | Buy |
+2,200
| New | +$269K | 0.01% | 303 |
|
|
2022
Q1 | – | Sell |
-50
| Closed | -$8K | – | 1045 |
|
|
2021
Q4 | $8K | Sell |
50
-75
| -60% | -$12K | ﹤0.01% | 862 |
|
|
2021
Q3 | $20K | Hold |
125
| – | – | ﹤0.01% | 640 |
|
|
2021
Q2 | $20K | Hold |
125
| – | – | ﹤0.01% | 624 |
|
|
2021
Q1 | $19K | Hold |
125
| – | – | ﹤0.01% | 601 |
|
|
2020
Q4 | $19K | Hold |
125
| – | – | ﹤0.01% | 576 |
|
|
2020
Q3 | $17K | Hold |
125
| – | – | ﹤0.01% | 514 |
|
|
2020
Q2 | $17K | Buy |
125
+50
| +67% | +$6.8K | ﹤0.01% | 506 |
|
|
2020
Q1 | $8K | Hold |
75
| – | – | ﹤0.01% | 538 |
|
|
2019
Q4 | $9K | Sell |
75
-1,000
| -93% | -$120K | ﹤0.01% | 568 |
|
|
2019
Q3 | $107K | Hold |
1,075
| – | – | 0.01% | 292 |
|
|
2019
Q2 | $117K | Buy |
+1,075
| New | +$117K | 0.01% | 284 |
|
|
2016
Q4 | – | Sell |
-225
| Closed | -$217 | – | 690 |
|
|
2016
Q3 | $217 | Buy |
+225
| New | +$217 | ﹤0.01% | 373 |
|